semaglutide prediabetes progression to type 2 diabetes Two-year effects of in adults with overweight or obesity: the STEP 5 trial Remission of type 2 diabetes:

It is administered as a once-weekly injection and is suitable for adults with a body mass index (BMI) of 30 or higher, or 27 or higher with at least one weight-related condition

In fact, the evidence became so compelling that in August of last year, the FDA approved semaglutide (Wegovy) for the treatment of non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis, based on the phase 3 ESSENCE trial

Strategies for Long-Term Management of Skin Health Long-term management involves not just treating the rash when it occurs but also taking steps to prevent it

Overall Health and Medical History A healthcare professional will consider factors such as other medical conditions, medication interactions, and potential side effects of semaglutide to determine if it is suitable for an individuals specific situation

Your personalized care plan includes scheduled check-ins, timely dose adjustments when needed, and access to our team for advice on managing side effects or making healthy lifestyle changes